Form D · Biotechnology
Cryoport, Inc.
Irvine, CA · CIK 0001124524
Offering snapshot reported Dec 31, 2018 · SEC filing
- Reported sold
- $25M Offering amount: $25M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Dec 14, 2018 As reported in this filing
Fundraising history
Reported soldDates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Dec 31, 2018 | Amendment | $25,000,000 | $0vs Dec 28, 2018 | 1 | SEC filing |
| Dec 28, 2018 | Initial | $25,000,000 | No comparison | 1 | SEC filing |
| Apr 20, 2016 | Initial | $2,525,746 | No comparison | 192 | SEC filing |
| Mar 15, 2016 | Initial | $46,156 | No comparison | 3 | SEC filing |
| Mar 3, 2015 | Initial | $50,000 | No comparison | 1 | SEC filing |
| May 16, 2014 | Initial | $1,584,173 | No comparison | 32 | SEC filing |
| Dec 20, 2013 | Initial | $305,000 | No comparison | 7 | SEC filing |
| Oct 11, 2013 | Initial | $4,127,202 | No comparison | 75 | SEC filing |
| Jun 29, 2009 | Amendment | $964,500 | $594,500vs May 13, 2009 | 25 | SEC filing |
| Jun 19, 2009 | Amendment | $964,500 | $594,500vs May 13, 2009 | 25 | SEC filing |
| May 13, 2009 | Initial | $370,000 | No comparison | Not reported | SEC filing |
| Aug 10, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
| May 11, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
| May 11, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
| May 11, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity, Other
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-329185
Cryoport, Inc. (the "Company") sold an aggregate of 1,000,000 shares of the Company's common stock at $10.00 per share and issued an aggregate principal amount of $15,000,000 of floating rate convertible notes (together, the "Transaction").
Convertible Notes
Source: Form D, filed Dec 31, 2018. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Richard J Berman | Director |
| Peter Berry | Director |
| Thomas Fischer | Director |
| Robert Hariri | Director |
| Carlton Johnson | Director |
| Dee Kelly | Executive |
| Ramkumar Mandalam | Director |
| Adam Michelin | Director |
| Richard Rathmann | Director |
| Jerrell W Shelton | Director, Executive |
| Larry G. Stambaugh | Director, Executive |
| Robert S. Stefanovich | Executive |
| Stephen Wasserman | Director |
| Edward J Zecchini | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:Irvine, CA, 92614